Shree Ram Proteins Limited Announces 16th AGM on March 5, 2026, with E-voting from March 2-4
Shree Ram Proteins Limited will hold its 16th AGM on March 5, 2026, via VC/OAVM. The agenda includes adopting FY24 audited financials, reappointing Mr. Navin Kumar Singh, and regularizing directors Mr. Akash Sureshbai Gajera and Mr. Yogesh Chandubhai Dhanani. Remote e-voting is available from March 2-4, 2026.
This is a standard procedural announcement regarding an upcoming AGM and does not involve any immediate material changes to the company's operations or financial performance.
The announcement is a routine corporate event (AGM notice) and does not contain any significant positive or negative financial or operational news.
Shree Ram Proteins Limited will hold its 16th Annual General Meeting (AGM) on Thursday, March 5, 2026, commencing at 11:00 AM IST. The meeting will be conducted through Video Conference (VC) / Other Audio Visual Means (OAVM).
The AGM agenda includes the adoption of audited financial statements for the financial year ended March 31, 2024, along with the reports of the Board of Directors and auditors. It also includes the appointment of a director in place of Mr. Navin Kumar Singh, who retires by rotation and offers himself for reappointment. Additionally, the meeting will seek to regularize the appointment of Mr. Akash Sureshbai Gajera and Mr. Yogesh Chandubhai Dhanani as Independent Directors.
The company will also seek ratification for the remuneration payable to M/s. Tadhani & Co., Cost Accountants, for the financial year ended March 31, 2025. The remuneration is not to exceed ₹50,000 plus applicable taxes and reimbursement of out-of-pocket expenses.
Members can cast their votes electronically through remote e-voting from Monday, March 2, 2026, at 10:00 AM IST, until Wednesday, March 4, 2026, at 5:00 PM IST. The record date for determining voting rights and eligibility for the AGM is February 26, 2026. The Annual Report for the financial year 2023-24, comprising the Notice for the AGM and audited financial results, has been enclosed with this communication.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.